IDEXX Laboratories (IDXX)
(Delayed Data from NSDQ)
$497.51 USD
-0.33 (-0.07%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $497.13 -0.38 (-0.08%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth B Momentum B VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
IDXX 497.51 -0.33(-0.07%)
Will IDXX be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for IDXX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IDXX
Why Is Penumbra (PEN) Down 4.8% Since Last Earnings Report?
IDEXX (IDXX) Expands Test Menu for the Catalyst Platform
IDXX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Is Idexx (IDXX) Up 5% Since Last Earnings Report?
IDEXX (IDXX) Witnesses Rising Expenses, Currency Issues
IDEXX (IDXX) Q1 Earnings Surpass Estimates, 2024 View Slashed
Other News for IDXX
Idexx Laboratories, Inc. (IDXX) Shares Cross Above 200 DMA
IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing Pancreatitis
Idexx Laboratories Takes Over #215 Spot From Fidelity National Information Services
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $7,500 Today
7 Surefire Stocks to Buy Each Time You Get a Paycheck